Form SC14D9C - Written communication relating to third party tender offer:
SEC Accession No. 0001193125-25-249440
Filing Date
2025-10-24
Accepted
2025-10-24 09:27:05
Documents
13

Document Format Files

Seq Description Document Type Size
1 SC14D9C d41892dsc14d9c.htm SC14D9C 18400
2 EX-99.1 d41892dex991.htm EX-99.1 25785
3 EX-99.2 d41892dex992.htm EX-99.2 18496
4 EX-99.3 d41892dex993.htm EX-99.3 56911
5 EX-99.4 d41892dex994.htm EX-99.4 18569
6 EX-99.5 d41892dex995.htm EX-99.5 9254
7 EX-99.6 d41892dex996.htm EX-99.6 9263
8 EX-99.7 d41892dex997.htm EX-99.7 12625
9 EX-99.8 d41892dex998.htm EX-99.8 9964
10 GRAPHIC g41892g1024120128253.jpg GRAPHIC 24340
11 GRAPHIC g70157dsp1a.jpg GRAPHIC 5739
12 GRAPHIC g70157dsp1aa.jpg GRAPHIC 7912
13 GRAPHIC g70157dsp1b.jpg GRAPHIC 6976
  Complete submission text file 0001193125-25-249440.txt   243663
Mailing Address 100 CARDINAL WAY REDWOOD CITY CA 94063
Business Address 100 CARDINAL WAY REDWOOD CITY CA 94063 (650) 649-1004
Adverum Biotechnologies, Inc. (Filed by) CIK: 0001501756 (see all company filings)

EIN.: 205258327 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC14D9C
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)

Mailing Address 100 CARDINAL WAY REDWOOD CITY CA 94063
Business Address 100 CARDINAL WAY REDWOOD CITY CA 94063 (650) 649-1004
Adverum Biotechnologies, Inc. (Subject) CIK: 0001501756 (see all company filings)

EIN.: 205258327 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC14D9C | Act: 34 | File No.: 005-88266 | Film No.: 251414518
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)